University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 1B-09-4


 
Description: A Multi-Center, Open-Label, Phase II Study to Evaluate the Safety and Efficacy of NKTR-102 (PEG-Irinotecan) When Given on a Q14 Day or a Q21 Day Schedule in Patients with Metastatic Breast Cancer Whose Disease has Failed Prior Taxane-Based Treatment.
Status: Open
Randomized? Yes


Researchers  
Principal InvestigatorTitle
Agustin GarciaM.D.

Data Management
NameTitle
Joanne SakamotoR.N.
Yvonne FloresD.M.
Anayansi MiloudD.M.
Jessica LevanoR.N.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.